Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug 8;2(4):548-554.
doi: 10.1016/j.adro.2017.08.001. eCollection 2017 Oct-Dec.

Factors influencing the utilization of prophylactic cranial irradiation in patients with limited-stage small cell lung cancer

Benjamin H Lok  1 , Jennifer Ma  1 , Amanda Foster  1 , Carmen A Perez  2 , Weiji Shi  3 , Zhigang Zhang  3 , Bob T Li  4 , Charles M Rudin  4 , Andreas Rimner  1 , Abraham J Wu  1
Affiliations

Factors influencing the utilization of prophylactic cranial irradiation in patients with limited-stage small cell lung cancer

Benjamin H Lok et al. Adv Radiat Oncol. .

Abstract

Purpose: Brain metastases are common in patients with limited-stage small cell lung cancer (LS-SCLC) due to the inability of most chemotherapeutics to penetrate the blood-brain barrier. Prophylactic cranial irradiation (PCI) is therefore recommended for use in patients with a good response to concurrent chemoradiotherapy. However, PCI is not always delivered; therefore, we investigated the reasons for PCI omission in patients who underwent therapy with curative intent.

Methods and materials: We retrospectively reviewed all patients with LS-SCLC who were treated with curative intent at our institution. Overall survival and cumulative incidence of brain metastasis were estimated by the Kaplan-Meier method. The Pearson χ2 test and Mann-Whitney U test were used to examine factors associated with PCI use, and prognostic factors were analyzed with Cox proportional hazards modeling.

Results: We examined 208 patients who were treated for LS-SCLC at our institution. A total of 115 patients (55%) received PCI. The most common documented reason for PCI omission was patient refusal due to neurotoxicity concerns (38%). Physician assessment of being medically unfit (33%) and of advanced age (8%) were the second and third most common reasons, respectively. Karnofsky performance status and clinical American Joint Committee on Cancer stage but not PCI were significantly associated with overall survival. Only clinical stage remained an independent factor on multivariate analysis.

Conclusions: Approximately half of patients with LS-SCLC ultimately receive PCI, generally for guideline-recommended reasons. The most common reason for PCI omission was patient concerns regarding neurotoxicity. Efforts to decrease PCI neurotoxicity, including hippocampal-sparing radiation and memantine use, may increase the use of this survival-improving intervention in eligible patients with LS-SCLC.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Kaplan-Meier survival curves of overall survival for all patients.
Figure 2
Figure 2
Cumulative incidence of brain metastasis with death as a competing risk.
See this image and copyright information in PMC

References

    1. Arriagada R., Chevalier T.L., Borie F. Prophylactic cranial irradiation for patients with small cell lung cancer in complete remission. J Natl Cancer Inst. 1995;87:183–190. - PubMed
    1. Knisely J., Sharma R., Goenka A., Halthore A. PCI in resected small-cell lung cancer. Lancet Oncol. 2016;17:e415. - PubMed
    1. Rudin C., Ismaila N., Hann C. Treatment of small-cell lung cancer: American Society of Clinical Oncology endorsement of the American College of Chest Physicians guideline. J Clin Oncol. 2015;33:4106–4111. - PubMed
    1. Schild S., Foster N., Meyers J. Prophylactic cranial irradiation in small-cell lung cancer: Findings from a north central cancer treatment group pooled analysis. Ann Oncol. 2012;23:2919–2924. - PMC - PubMed
    1. Auperin A., Arriagada R., Pignon J.P. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med. 1999;341:476–484. - PubMed

LinkOut - more resources